Fast Market Research

New Market Report: Ventria Bioscience - Product Pipeline Review - 2013

New Pharmaceuticals market report from Global Markets Direct: "Ventria Bioscience - Product Pipeline Review - 2013"


Boston, MA -- (SBWIRE) -- 02/03/2014 -- Global Market Direct's pharmaceuticals report, "Ventria Bioscience - Product Pipeline Review - 2013" provides data on the Ventria Bioscience's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Ventria Bioscience's corporate website, SEC filings, investor presentations and featured press releases, both from Ventria Bioscience and industry-specific third party sources, put together by Global Markets Direct's team.


- Ventria Bioscience - Brief Ventria Bioscience overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ventria Bioscience human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Ventria Bioscience with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ventria Bioscience's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Ventria Bioscience's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ventria Bioscience in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ventria Bioscience's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ventria Bioscience.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ventria Bioscience and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Pantarhei Bioscience BV - Product Pipeline Review - 2013
- Icon Bioscience, Inc. - Product Pipeline Review - 2013
- Alligator Bioscience AB - Product Pipeline Review - 2013
- Altor BioScience Corporation - Product Pipeline Review - 2013
- Diarrhea - Pipeline Review, H1 2013
- Celgene Corporation - Product Pipeline Review - 2013
- Diarrhea - Pipeline Review, H2 2013
- Inflammatory Bowel Disease - Pipeline Review, H1 2013
- Chemotherapy Effects - Pipeline Review, H2 2013
- Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013